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ABSTRACT  A cytoskeleton-associated glycoprotein of 130-kilodalton molecular mass (GP 130) 
was  purified  from  a  nonionic  detergent-insoluble  fraction  of  10-16-d-old  chicken  embryo 
brains. GP 130 is tightly associated  with other proteins in actin-containing complexes (Moss, 
D.  J.,  1983,  Eur.  I.  Biochem.,  135:291-297); thus,  pure  protein  preparations were obtained 
only after the partial  dissociation of the complexes with the zwitterionic detergent, dimethyl 
dodecyl glycine (EMPIGEN  BB), followed  by ion-exchange chromatography and electropho- 
resis on preparative SDS polyacrylamide gels. Specific monoclonal and polyclonal antibodies 
were raised to GP 130 and used to examine its distribution in the developing nervous system. 
Experiments  with these antibodies revealed that GP 130 is confined to nervous tissue and is 
restricted to the surface of neurons in cultures derived from  both the central and peripheral 
nervous systems. This novel glycoprotein  is immunologically  unrelated to the neuronal cell 
adhesion molecule  (N-CAM),  or to vinculin,  a protein of similar  molecular mass which  has 
been suggested  to link actin filaments to the plasma  membrane.  In the developing chicken 
embryo brain, GP 130 is first detectable around day 8 after fertilization and increases to -50% 
of its adult level  by embryonal  day  13.  In contrast,  no increase  is observed  over a similar 
developmental period in sciatic nerve. In the adult chicken, GP 130 is most abundant in brain 
and has a particularly high content in areas rich in dendrites and synapses. 
Membrane components, particularly glycoproteins, that are 
associated with the cytoskeleton may well play a crucial role 
in the development of  the nervous system. Dynamic processes 
such as the generation of cell shape, locomotion, the forma- 
tion  of cellular contacts,  and  redistribution  of membrane 
receptors, require a force-generating cytoskeletal system able 
to respond to external signals (reviewed in reference 1). This 
is  of particular importance  for the  numerous  events  that 
precede and maintain the establishment of correct connec- 
tions between neurons. Axonal extension requires the con- 
tractile machinery within the growth cone to interact with the 
substratum via a mechanically robust linkage possibly involv- 
ing transmembrane glycoproteins. There is a distinct prefer- 
enee for particular pathways, and later-arriving growth cones 
follow the axons already present by fasciculation into nerve 
bundles (2,  3),  presumably moving along surface receptors 
that are firmly attached to the axonal cytoskeleton. An asso- 
ciation between surface proteins and the cytoskeleton is also 
likely to play a vital part in synapse formation. Recognition 
between neurons and their target ceils will  be mediated by 
surface molecules, such as glycoproteins, but the segregation 
and stabilization of the receptors that ultimately leads to the 
formation of a  mature synaptic junction, probably requires 
them to be coupled to the cytoskeleton. Many cytoskeleton 
components have been found to occur in synaptic junctions 
and postsynaptic densities (4, 5), and actin is found enriched 
in dendritic spines (6) and in the neuromuscular  junction (7). 
Cytoskeleton-associated glycoproteins have been identified 
in a number of tissues (8, 9) by virtue of their insolubility in 
detergent. In a similar approach in this laboratory, a number 
of coneanavalin A (Con A)l-binding glycoproteins were iden- 
i Abbreviations used in this paper: BSA, bovine serum albumin; CNS, 
central nervous system; Con A, concanavalin A; eMCF, enriched 
membrane--cytoskeleton  fraction; F1, fluorescein;  GalC, galactocere- 
broside; GAM-Ig, goat anti-mouse immunoglobulin; GAR-Ig, goat 
anti-rabbit immunoglobulin; GP 130, cytoskeleton-associated  glyeo- 
protein of 130-kilodalton molecular mass; kD,  kilodalton; MCF, 
membrane--cytoskeleton fraction; N-CAM, neuronal cell adhesion 
molecule; PBS, phosphate-buffered saline; PNS, peripheral nervous 
system; RAM-Ig, rabbit anti-mouse immunoglobulin; Rd,  rhoda- 
mine; rGP 130,  rabbit antibodies against GP 130; RIA, radio immune 
assay. 
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taining complexes that were obtained from pure cultures of 
chicken sympathetic neurons and whole chicken brain (10). 
In the present communication, we report the derivation of 
monoclonal and polyclonal antibodies against the most prom- 
inent glycoprotein of  this complex, a protein of 130-kilodalton 
(kD) molecular mass (GP 130). We also describe the use of 
these reagents to establish the distribution of GP 130 in the 
developing and adult nervous system. 
MATERIALS AND  METHODS 
Antisera used in this study were kindly provided by Dr. J. Couchman (rabbit 
anti-chicken smooth muscle vinculin) (11) and Ms. D. Cox (guinea pig anti- 
bovine fibronectin)  (12)  (Unilever Research Laboratories,  Bedford,  U.K.). 
Rabbit antibodies against the neuronal cell adhesion molecule (N-CAM) (13) 
were  a  generous gift from Dr.  R.  Brackenbury and Dr.  G.  Edeiman (The 
Rockefeller University, New York City, New York), and Dr. J. Wood (Welcome 
Research Laboratories, Beckenham, U.K.) kindly supplied the RT 97 mono- 
clonal antibody against the neurofdament 210-kD polypeptide (14).  Bovine 
corneal endothelial cells (15) were generously  donated by Dr. C. Kintner (MRC 
Cell Biophysics Unit, King's College, London, U.K.). 
Purification of GP 130:  Brains from 10-16*d-old  chicken embryos 
(40-50 g wet wt) were  freed of meninges and homogenized at 4°C in 2 mM 
MgCI2, 0.2 mM dithiothreitol, 10 mM Tris/HC1, pH 7.6 (buffer A), with 1 mM 
phenylmethylsulfonyl  fluoride and Nonidet P-40 (1-5%) to give a 5:1 (wt/wt) 
detergent/protein ratio. The detergent-insoluble material was pelleted for 30 
min at 100,000 g and resuspended in buffer A. Fractions were separated for 3 
h at 100,000 g on a discontinuous sucrose gradient consisting of layers of 50, 
30, and  10% sucrose in buffer A. According to a  previous report from this 
laboratory (10), most of the GP 130-containing material collects at the 10-30% 
interface.  This material was sampled, diluted in buffer A, and pelleted at 
100,000  g  as the  membrane--cytoskeleton fraction  (MCF).  The pellet  was 
homogenized  in 10 mM Tris-HCl, pH 7.6, and partly dissociated  by the addition 
of a  30%  solution of dimethyl dodecyl glycine (EMPIGEN BB, Albright & 
Wilson Ltd., Whitehaven, Cumbria, UK) to a final concentration of 2% (vol/ 
vol) or 0.67% detergent. This fraction was then applied to a DEAE-cellulose 
ion-exchange column (DE52, Whatman, Springfield  Mill,  Maldstone, Kent, 
U.K.) (3-cm diameter x  30 cm) equilibrated in 10 mM Tris-Ha, pH 7.6, and 
0.2%  EMPIGEN BB (buffer B). The column was washed with two column 
volumes of buffer B. Proteins were eluted with a gradient of 0-150 mM NaC1 
in buffer B and collected in 10-ml fractions. After analysis by SDS PAGE (16), 
GP 130-containing fractions were pooled as enriched membrane-cytoskeleton 
fraction  (eMCF) and concentrated by vacuum dialysis.  Pure GP  130  was 
obtained by preparative SDS-gel  electrophoresis on 7%  polyacrylamide gels 
(17). Separated bands were detected by brief staining of  the gels with Coomassie 
Brilliant Blue (18). The band at 130 kD was excised and eluted electrophoret- 
ically. Before their use in immunization procedures, electrophoresis buffer and 
excess SDS, were removed from GP  130 on a Sephadex G25 column (l-cm 
diameter x  5 cm; Pharmacia, Uppsala, Sweden).  In both gel procedures, ox 
neurofilaments (tool wt 200,000,  156,000, and 70,000),  phosphorylase b (tool 
wt 95,000), and actin (mol wt 43,000) were used as molecular weight standards. 
Protein concentrations were determined after spotting samples onto filter 
paper and staining with Coomassie Brilliant Blue G  250 (19). Bovine serum 
albumin (BSA) was used as a standard. 
Concanavalin A (ConA)-binding  glycoproteins  were detected by SDS PAGE 
with ~z~I-Con  A as described previously (10). 
Monoclonal Antibody Production:  BALB/c mice were immu- 
nized with detergent-insoluble brain fractions of increasing GP  130 content. 
The first injection was with 200 ~g of MCF protein in Freund's complete 
adjuvant, the second, after 2 wk, was with 90/zg of eMCF protein in Freund's 
incomplete adjuvant. Thereafter, the mice were boosted four times at intervals 
of 20, 16, 20, and 22 d with 25-30 vg of pure GP 130 eluted from preparative 
SDS  gels. GP  130 was applied intraperitoneally in all cases.  Serum activity 
against purified GP 130 was determined after each boost in an enzyme-linked 
immunosorbent assay (20)  carried out essentially as described below for a 
radioimmune assay (RIA). Rabbit anti-mouse immunoglobulin  (RAM-Ig) con- 
jugated to alkaline phosphatase as described in reference 21  was used as a 
secondary antibody. Serum titers were considered satisfactory at 1:10,000. For 
the final boost, 3 d before sacrifice, pure GP 130 was injected into the tail veins 
of the mice. Spleen lymphocytes from these mice were fused with hypoxan- 
thine-aminopterine-thymidine-sensitive SP2/0-Agl4 (22)  myeloma cells ac- 
cording to published procedures (23, 24). Cells were seeded onto four trays of 
NUNC 24 (NUNC A/S, Roskilde, Denmark) dishes, which were precondi- 
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tioned with feeder layers of intraperitoneal macrophnges. Hybrids were selected 
by growth in hypoxanthine-aminopterine-thymidine-containing  medium and 
grew in 80%  of the wells. Six hybridoma lines (mGP 130-1 to mGP 130-6) 
from one fusion were selected  on the basis of a RIA and subcloned twice by 
limiting dilution on macrophage feeder layers.  Ascites fluid was produced in 
pristane-treated BALB/e-exbreeders and, for some experiments, subjected to 
precipitation with 50% (NI-L)2SO4  before use. 
Screening  of  Hybridoma  Cells for  Antibody  Produc- 
tion:  Clones producing antibodies to GP 130 were detected in a RIA with 
eMCF in the initial, and with pure GP 130 in the subsequent test. Briefly,  1-2 
#g of protein in 50-100 #1 of phosphate-buffered saline (PBS) (pH 7.4) were 
bound to each well of polystyrene plastic (NUNC A/S, Roskilde, Denmark) in 
an overnight incubation at 4°C. Unbound protein was washed off with PBS, 
and the remaining free binding sites on the plastic were blocked for 2-3 h with 
1%  immunoglobulin-free BSA in PBS.  Antibodies in undiluted hybridoma 
culture  supernatants were  incubated in  the protein-coated wells  and their 
binding to the antigen detected after subsequent incubations in presence of 1% 
BSA with 12SI-RAM-Ig  (Fab)2-fragments (50,000  cpm/ml, Amersham Bucks, 
U.K.) or  RAM-Ig (Nordic,  Maidenhead, Berks,  U.K.,  10 #g/ml) and  ~25I- 
Protein A (50,000 cpm/ml). Each incubation step was carded out for 1-2 h at 
37°C and was followed by extensive washing of the wells with PBS. Individual 
wells  were  dried  and  counted  in  a  Packard  Gamma scintillation counter 
(Packard Instrument Co., Inc., Downers Grove, IL).  Protein A (0.5 rag) was 
iodinated using 1 mCi of Bolton-Hunter reagent (25). 
Production  of a  Rabbit  Antiserum  against GP  130:  The 
primary immunization of a  Dutch rabbit was intramuscular with 400 ~g of 
pure GP 130 in Freund's complete adjuvant. The animal was boosted after 4 
and 8 wk with  150 and 100 ug of protein in Freund's incomplete adjuvant. 
Thereafter, GP 130 (40-100 vg) was applied intravenously in PBS in monthly 
intervals. Serum activity against GP  130 was first detected on immunoblots 
after four injections. 
Detection  of Antibody  Binding to  Proteins Separated  by 
SD3 PACE:  Proteins separated by SDS PAGE on minigels (0.4-0.5-mm 
thick)  (16)  were  transferred  electrophoretically  to  nitrocellulose  paper 
(Sehleicher  & Schull, Dassel, Federal Republic of Germany) (26). The transfer 
was essentially complete after 4 h for proteins of <150 kD. Unspecific binding 
sites on the nitrocellulose paper were blocked by an overnight incubation with 
3% BSA in l0 mM Tris-HCl, pH 8.4,  150 mM NaC1, and 0.1% NaN3 (buffer 
C).  Monoclonal or rabbit  antibodies (l:50-1:100)  were  incubated with the 
paper and the monoclonal antibodies were followed by incubations with RAM- 
Ig (Nordic, Maidenhead, Berks, U.K., 100 ug/ml). Binding of antibodies from 
both species was detected by t2~l-Protein A (500,000 cpm/ml). All incubations 
were carried out for 1 h at room temperature in buffer C containing 3% BSA 
and were followed by l-3-h washes with at least five changes of buffer C. The 
nitrocellulose paper was dried and exposed for autoradiography with Kodak 
X-Omat film (Eastman Kodak Co., Rochester, NY) at -70"C with Cronex 
(DuPont Instruments, Wilmington, DE)  intensifying screens (27).  In  some 
experiments the antibodies were bound directly to the separated proteins by 
overlaying the gel with undiluted mGP 130 culture supernatants (28). These 
gels were processed as described above, stained with Coomassie Brilliant  Blue, 
dried, and exposed for autoradiography. Bands labeled with tz~I were identified 
by matching the labeled bands with the Coomassie Brilliant  Blue-stained gel. 
Relative amounts of GP 130 in different samples were quantitated by densito- 
merry of the labeled bands on immunoblots. This method compared samples 
within a single autoradiograph by using exposure times so that the increase in 
intensity was linear with respect to the time of exposure. 
Cell Culture:  Cultures of sympathetic neurons for biochemical analysis 
were  prepared essentially free of non-neuronal cells as previously described 
(18). For immunofluoresceoce,  sensory and sympathetic ganglia were dissected 
from 10-11-d-old chicken embryos in Hanks' balanced salt solution with or 
without Ca  +* and Mg  ++, respectively. The ganglia were dissociated after trypsin 
treatment (0.25% in Hanks  +  balanced salt solution without Ca  ++ and Mg  ++ for 
30 min at 37"C) and grown in LI 5 medium (Gibco Laboratories, Grand Island, 
NY) containing 10% fetal ealfserum, 0.5% methylcellulnse, 100 U/mi penicil- 
lin,  100  ug/ml streptomycin, 2  mM glutamine, 0.6 g/1 glucose, and nerve 
growth factor.  The cells were seeded onto the extracellular matrix of bovine 
corneal endothelial cells (15) on glass coverslips. 
Cultures from the central nervous system (CNS)  were prepared from the 
cerebral hemispheres  of 6-7-d-old, or the cerebella of 13-d-old chicken embryo 
brains. The tissues  were freed of their meninges  and dimociated after incubation 
with trypsin by gentle trituration through a wide-bore pipette. Aggregates were 
removed by passage of the cell suspension  through a fine nylon mesh. The cells 
were plated onto extmcellular matrix glass coverslips in NUNC 24-well plates 
(NUNC A/S, Roskilde, Denmark) in Dulbecco's modified Eagle's medium 
with 10% fetal ealf serum at a density of 1-2 ×  105 cells per well and stained for indirect immunolluorescence  after 2-6 d in culture. 
Indirect  Immunofluorescence:  Indirect  immunofluorescence 
staining was carried out on primary cultures from the CNS and peripheral 
nervous system (PNS).  Cultures were incubated sequentially with one of the 
monoclonal mGP 130 antibodies (undiluted hybridoma culture superoatants 
or  ascites fluid  [1:50  or  1:100])  and  rhodamine (Rd)-conjugated RAM-Ig 
(Nordic,  1:50). In some experiments the staining intensity of the monoclonal 
antibodies was enhanced by incubations with unlabeled RAM-Ig (100 ~g/ml, 
Cappel Laboratories, Inc., Coehranville, PA) and Rd-goat anti-rabbit immuno- 
globulin (GAR-Ig) (1:100,  Cappel Laboratories, Inc.) as secondary antibodies. 
Binding of rabbit antibodies against GP  130 (rGP  130) (1:50  or  1:100) was 
detected  with  Rd-GAR-lg (1:100,  Cappel  Laboratories,  Inc.).  All antibody 
incubations were in L15-medium with 10% fetal calf serum and 0.02% sodium 
azide for 30 min at room temperature. After each incubation the coverslip 
cultures were washed by immersion through five changes of L 15-medium. The 
staining with GP  130 antibodies was always carried out on living cells. The 
cultures were ix)stfixed with acidic ethanol (ethanol/acetic acid, 95:5,  vol/vol) 
at -20"C after the incubations with GP  130 antibodies and the appropriate 
fluorochrome conjugates. The coverslip cultures were mounted with gelvatol 
(29).  Staining was  examined under  a  Zeiss fluorescence microscope with 
appropriate filters for lluorescein and rhodamine. 
Suspension staining of living cells was carried out as previously described 
(30), except that, before examination, the cells were fixed with acidic ethanol 
to the glass coverslips. 
In double-labeling experiments of GP  130 with cell type-specific  markers, 
staining with GP  130 antibodies followed  by the appropriate fluorochrome 
conjugate was always carried out first.  Indirect double immunofluorescence 
was performed sequentially with one of  the mGP 130 antibodies, Rd-conjugated 
goat anti-mouse  immunoglobulin  (Rd-GAM-Ig), rabbit antibodies against neu- 
rofilament 70-kD polypeptide (1:40)  (31) or filamin (1:40)  (32),  and finally 
fluorescein (F l)-conjugated GAR-Ig ( 1:50, Nordic).  Alternatively, rGP 130 and 
Rd-GAR-Ig were used in combination with a  monoclonal antibody against 
neurofilaments (1:50)  (14) and FI-GAR-Ig (1:100,  Cappel).  Before the appli- 
cation of antibodies against intraceUular filaments, the cultures were fixed with 
acidic  ethanol.  Double labeling of GP  130  with  fibroneetin, a  marker for 
fibroblasts  and leptomeningeal cells (33) was carried  out in an identical way. 
In this case the cultures were stained with IGP 130 and Rd-GAR-Ig, fixed,  and 
then exposed to guinea pig antibodies against  flbronectin  (1:50) (12) and F1- 
goat anti-guinea pig immunoglobulin (1:50, Nordic). For double labeling of GP 
130 and galactocerebroside  (GalC), a marker for oligodendrocytes and Sehwann 
cells (34, 35), the labeling was sequentially with rGP 130, Rd-GAR-Ig, mono- 
clonal antibody against GalC (1:200) (30), and F1-GAM-IgG3 (1:50, Nordic). 
These cultures were postfixed aRer having completed all the incubation steps. 
Secondary antibodies were cross-absorbed  against  mouse or rabbit  immuno- 
globulin or were affinity-purilled  on immobilized lg. 
RESULTS 
Purification  of GP 130 
GP 130 was isolated from whole brain homogenates in four 
steps as shown in Fig.  I a.  Components of the cytoskeleton 
were obtained by extraction with nonionic detergent followed 
by sedimentation (Fig.  I a, lane  I). The pellet was enriched 
for  GP  130  by  fractionation  on  a  discontinuous  sucrose 
gradient. GP  130 was found to accumulate at the  10-30% 
interface of the gradient together with about 20 other poly- 
peptides including actin (Fig.  I a, lane 2). As shown previously 
by chromatography on Sepharose 4B, these polypeptides are 
associated in large complexes (10). The first two purification 
steps depend on the association ofGP  130 with actin or other 
molecules of the cytoskeleton; however, for further purifica- 
tion it was necessary to break up the actin-containing com- 
plexes.  The zwitterionic detergent EMPIGEN  BB proved to 
dissociate the complexes sufficiently without interfering with 
subsequent purification  steps.  By  ion-exchange chromatog- 
raphy on DEAE cellulose, a  number of proteins were  sepa- 
FIGURE  1  Purification of GP 130. (a) Steps in the purification of GP 130 from 10 to 13-d-old chicken embryo brains. (Lane 1) 
Detergent-insoluble  material. (Lane 2) MCF from 10-30% interface of the discontinuous sucrose gradient. (Lane 3) Peak  fractions 
from the DEAE ion-exchange column (eMCF). (Lane 4) GP 130 isolated from eMCF by 7% preparative SDS PAGE. Numbers  in 
both figures show the molecular mass x  10  -3. (b) Fractions of MCF were eluted from a DEAE column and analyzed on 9% SDS 
polyacrylamide  gels. Proteins were detected with Coomassie Brilliant Blue and glycoproteins with 12sl-Con  A. 
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similar clectrophoretic mobility. The elution profile through- 
out the column was analyzed by SDS PAGE; the glycoproteins 
were detected with Coomassie Brilliant Blue or by autora- 
diography of gels after incubation with 125I-Con A. The GP 
130-containing  peak fractions are shown in Fig.  1  b. Identical 
elution profiles were obtained with both stains, indicating that 
GP 130 is the major, if not the only 130-kD protein. There- 
fore, GP  130-containing column  fractions were pooled as 
eMCF  (Fig.  1  a,  lane  3)  and  subjected to  preparative gel 
electrophoresis as the final step in the purification of GP 130 
(Fig.  I a, lane 4).  A Con A-binding glycoprotein of slightly 
lower electrophoretic  mobility than 130 kD could be separated 
from GP 130 by reducing the percentage of polyacrylamide 
from 9  to  7%,  thus increasing the distance  between these 
proteins for preparative SDS PAGE. From 150-200 brains of 
10 and  16-d-old chicken embryos, -0.5 nag of GP  130, was 
routinely isolated with a percentage yield of 10-15%. 
Production and Characterization  of Monoclonal 
and Polyclonal Antibodies 
For the production of monoclonai antibodies, injection of 
BALB/c mice with increasingly pure GP 130 proved to elicit 
FIGURE 3  Comparison of 
N-CAM and GP 130. West- 
ern  blots were  incubated 
with either anti-N-CAM or 
rGP  130 followed by 12Sl- 
Protein A. (Lane I) 8.5-/~g, 
10-d-old embryo brain de- 
tergent -  soluble fraction. 
(Lane  2)  3.5-/~g, 10-d-old 
embryo  brain  detergent- 
insoluble fraction. (Lane 3) 
eMCF. 
good serum titers for this protein. The fusion of spleen lym- 
phocytes from one mouse with SP2/0-AgI4 myeloma cells 
produced six hybridoma lines (mGP  130-1 to mGP  130-6) 
reacting  with  pure  GP  130  in  a  RIA.  In  addition,  nine 
hybridoma clones secreting antibodies that bound to mole- 
cules in the eMCF fraction in the RIA and stained peripheral 
neurons in  indirect immunofluorescence were isolated and 
kept frozen for later reference. 
In  Ouchtedony double  diffusion (36)  with  class-specific 
rabbit or goat anti-mouse immunoglobulins, all mGP  130 
antibodies were identified to be of the IgG1 subclass. 
The antigen specificity of each of the mGP 130 antibodies 
was demonstrated in two ways: (a) Gels with separated MCF 
and  eMCF  were  overlaid with  mGP  130  antibodies  and 
processed for autoradiography. The gel band labeled by the 
monoclonal antibodies could be matched up with a Coomas- 
sie-stained protein of 130 kD.  In Fig.  2a the specificity of 
mGP 130-2, mGP 130-3, and mGP 130-4 (lanes 2, 3, and 4, 
respectively) for GP 130 is shown. (b) Western blots of whole 
brain homogenates demonstrated that the monoclonal anti- 
bodies recognized only a protein of 130 kD out of a greater 
variety of polypeptides. In Fig. 2 b immunoblots with mGP 
130-1,  mGP  130-5,  and  mGP  130-6  (lanes  3,  4,  and  5, 
respectively) are shown. Similarly, the polyclonal antiserum 
for GP 130 was shown on gel overlays and immunoblots to 
be monospecific for the 130-kD glycoprotein (Fig 2 b, lane I). 
FIGURE 2  Specificity  of monoclonal and polyclonal antibodies. (a) 
9% SDS polyacrylamide  gels of eMCF were incubated with culture 
supernatants  and  followed by  '2SI-RAM F(ab)2 fragments  before 
staining with Coomassie Brilliant Blue. The relative intensities of the 
bands are not related to the binding properties of the antibodies 
because variable concentrations of the antibodies and  different 
exposure times were used. (Lane /) eMCF stained with Coomassie 
Brilliant Blue. (Lane 2) mGP 130-2. (Lane 3) mGP 130-3. (Lane 4) 
mGP  130-4.  (b)  5  /~g of whole  brain  homogenates of  13-d-old 
embryo brains  were separated  on  7% polyacrylamide gels and 
transferred  to nitrocellulose. Monoclonal antibodies (ascites fluid 
[I :100]) were incubated with the paper and followed by RAM and 
~2Sl-Protein A. The rabbit antiserum  (1:50) was followed by  ~2Sl- 
Protein A only. (Lane I) rGP 130. (Lane 2) Brain homogenate  stained 
with Coomassie Brilliant Blue. (Lane 3) mGP 130-I. (Lane 4) mGP 
130-5. (Lane 5) mGP 130-6. 
GP 130 Is Unique to Nervous Tissue 
As a  first step in the characterization of GP  130,  it was 
necessary to estabhsh if GP 130 is related to known neuronal 
or  cytoskeleton-associated proteins.  In  preparations  from 
chicken brain the neuronal cell adhesion molecule N-CAM 
(l 3) was not recognized by the polyclonal antiserum against 
GP  130. Conversely, rabbit antibodies against  chicken N- 
CAM (37) did not bind to GP 130 on immunoblots (Fig. 3). 
It  should  be  pointed  out  that  N-CAM  also  has  different 
solubility properties being largely extracted in  1%  Nonidet 
40, whereas GP 130 is largely resistant to this detergent. When 
equal amounts of protein from both detergent-soluble and 
insoluble fractions are examined on gels, GP  130 is usually 
two- to threefold enriched in the detergent-resistant fraction. 
Antibodies against chicken smooth muscle vinculin (l l), a 
130-kD protein that links actin filaments to the plasma mem- 
brane (38), and the related 150-kD plasma membrane protein, 
meta-vinculin (39), did not detect GP 130 in brain tissue on 
immunoblots (data not shown). 
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Distribution of GP 130 in Chicken  Tissues 
Embryonal day 
10  Adult 
Breast muscle  ND  - 
Heart  -  - 
Liver  -  - 
Lung  -  - 
G i  zza rd  N D  - 
Spleen  ND  - 
Skin  -  ND 
Brain  +  + 
5/~g of each tissue was processed for immunoblots as described in Materials 
and Methods. On one occasion >10 #g was tested with the same results. A 
negative result corresponds to <5*/. of the amount in adult brain or <0.01% 
of the total protein. 
Cytoskeleton-associated glycoproteins have been character- 
ized from erythrocytes (8) and intestinal brush border (40). 
To examine the relation of GP  130 to these proteins, deter- 
gent-resistant fractions were prepared from both sources and 
tested with the polyclonal GP 130 antiserum on immunoblots. 
In neither preparation were bands labeled in the 90-140 kD 
region, although weak staining of low-molecular-weight ma- 
terial was occasionally seen. As the molecular weights of these 
latter  bands  varied with  the  experiments,  it  is difficult  to 
comment on a  possible cross-reactivity. From these experi- 
ments, GP  130 appeared to be unrelated to known proteins 
of similar molecular weight or potentially similar properties. 
A  variety of tissues from both the embryonic and adult 
chicken were examined for the presence of GP 130 with the 
monoclonal and polyclonal antibodies on immunoblots. The 
result of this survey is summarised in Table I. GP  130 was 
found only in tissues from the nervous system. Brain or spinal 
cord from mammals (rat, mouse, calf, and ox) and from an 
amphibian newt (Notophtalmus viridescens, from Lee's Newt 
Farm, Oak Ridge, TN) did not contain GP 130 when tested 
in a similar way. Only a reptile, green lizard (Lacerta viridis), 
was found to express GP 130 in nervous tissue. 
GP 130 Is Expressed on Neuronal Cell Surfaces 
In order to examine the cell type specificity of GP  130 in 
cells of the central and peripheral nervous system, we stained 
cultures of brain and peripheral ganglia (sensory and sympa- 
thetic) in indirect immunofluorescence with mGP  130  and 
rGP 130 antibodies. These experiments revealed that GP 130 
is expressed on neurons in both the PNS and CNS. Fig. 4, a 
and  b  show  the  surface  labeling  of cultured  sympathetic 
neurons  with  mGP  130-2.  Neurons  in  these  cultures  are 
readily distinguished from non-neuronal cells by morpholog- 
ical and immunological criteria. Double immunofluorescence 
labeling with rGP 130 and a monoclonal antibody against the 
210-kD component of neurofilament (14) confirmed the neu- 
ronal  restriction  of GP  130.  In Fig.  4,  d-f an  overlapping 
pattern of staining is seen on most neurites, the only exception 
being some very thin neurites that appear to be stained only 
by the rGP 130 antibody. All but one of the monoclonal and 
the polyclonal antibodies against GP 130 stained neurons in 
an identical way over their entire cell surface including the 
growth cones of younger neurites (Fig. 4 c). Only mGP 130-4 
did not detect an antigen determinant accessible to this anti- 
body on living cells or cells fixed with 1% paraformaldehyde, 
methanol, or acidic ethanol.  Non-neuronal cells in cultures 
from the PNS were identified by the positive staining with a 
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rabbit antibody against filamin (32),  an actin-cross-linking 
protein, and showed quite distinct morphologies and staining 
patterns from GP 130-stained cells (data not shown). 
In  cultures  from  the  cerebral  hemispheres  of 6-7-d-old 
chicken embryos, GP  130  was also  found  on cells with  a 
neuronal morphology (Fig. 5, a and b). An overlapping stain- 
ing pattern was seen with neurofdament-positive cells (Fig. 5, 
c-e). In older cerebellar cultures (corresponding to a  17-d-old 
chicken  embryo),  no  staining  of GP  130  antibodies  was 
detected on GalC-positive oligodendrocytes (Fig.  5, f-h). GP 
130 was always found on process-bearing cells and never on 
flat cells expressing fibronectin or filamin (putative fibroblasts 
and protoplasmic astrocytes). There are, at present, however 
no satisfactory criteria for the identification of astrocytes in 
chicken brain.  Antibodies against human,  rat,  or fish glial 
fibrillary acidic proteins, an intermediate filament specific to 
astrocytes (41),  do  not  cross-react with  cultured  astrocytes 
from chicken, and it is not clear whether filamin is expressed 
on fibrous astrocytes. However, it is unlikely that under the 
chosen culture conditions fibrous astrocytes will develop in 
these cultures. From these data GP  130 appears, at present, 
as a marker molecule for chicken neurons. 
The immunofluorescence staining indicated that GP  130 
molecules are exposed on the neuronal plasma membrane. 
When cells were fixed with methanol or acidic ethanol before 
the application of GP 130 and fluorochrome-conjugated an- 
tibodies,  no staining of membrane or intracellular antigens 
could  be detected.  Because  these  fixation methods usually 
preserve the cytoskeleton, it seems probable that GP 130 was 
extracted or its antigenic sites were changed by organic sol- 
vents.  Consequently,  we  cannot  tell  from  these  results, 
whether GP 130 is present on intracellular membranes. How- 
ever, biochemical analysis of intact sympathetic neurons in 
5-d-old cultures after treatment with trypsin suggested that 
most of GP 130 is located on the plasma membrane, while 
internal  membranes and  vesicles  have  relatively little.  As 
shown in Fig. 6, after treatment with trypsin for 1 h, 90% of 
GP 130 was degraded in intact neurons, whereas the neuro- 
filament 70-kD polypeptide--a prominent intracellular com- 
ponent-was unaffected in the same sample. 
GP 130 Increases with Time in Neuronal Cultures 
To relate the expression of GP 130 to a particular process 
during neuronal development, sympathetic neurons from 10- 
d-old chicken embryos were allowed to regenerate in culture. 
GP  130  was  examined  on  cells without  neurites,  neurons 
passing through the early phases of neurite outgrowth, and 
after an elaborate network of fasciculated axons had formed. 
The sympathetic ganglia were dissociated with trypsin. This 
cell suspension was immediately stained in indirect immu- 
nofluorescence with  rGP  130  antiserum.  GP  130  was  not 
detectable on the surfaces of any of these cells.  Within 4 h, 
however,  some  staining  with  GP  130  antibodies  could  be 
observed on  rounded  neurons.  These  cells were  prevented 
from attaching to a solid substratum by agitating them for 30 
s  at  intervals  of 5  min  on  a  vibrating  platform.  Besides 
indicating the trypsin sensitivity of GP 130, this observation 
showed that the expression of GP 130 is independent of the 
formation of neurites. When the same material was analyzed 
on  immunoblots,  GP  130  could  not  be detected,  possibly 
indicating a different level of sensitivity of the applied meth- 
ods. However, within 24 h, during which the cells had formed 
growth cones and extended short axons, the content of GP 
130 had recovered and exceeded the starting level in the  10- 
Neuronal Cytoskeleton-associated Surface GIvcoprotein  1807 FIGURE 4  Cell-type specificity of GP 130 in the PNS (a and b). Living cultures from the sympathetic  ganglia of 10-d-old chicken 
embryos were stained after 3 d in vitro sequentially  with mGP 130-2 (1:100), RAM-Ig (1:100), and Rd-GAR-Ig (1:100). Cells with 
a neuronal morphology  are stained. (a) GP 130. (b) Interference optics. (c) Growth cone in a 24-h culture from the sensory ganglia 
of a 10-d-old chicken embryo stained with rGP 130 (1:50) and Rd-GAR-Ig (1:100) before fixation. (d, e, and f) Double labeling  of 
GP 130 and neurofilaments: 2-d-old cultures  from the sensory ganglia of 10-d-old chicken embryos were stained with rGP 130 
(1:50) and Rd-GAR-Ig (1:100). After fixation with acid ethanol, neurofilaments were stained with the RT 97 monoclonal anti- 
neurofilament  (1:50) and FI-GAM-Ig (1:100). An overlapping  staining pattern is seen on most neurites. Note: the FI bleaches more 
rapidly than the Rd while taking the photograph. (d) GP 130. (e) Neurofilaments.  (f) Phase contrast. Bar, 10 ~m. x  650. 
FIGURE 5  Cell-type specificity of GP  130 in the CNS (a and  b).  Cultures  from the cerebral hemispheres  of 6~d-old chicken 
embryos were stained after 3 d in vitro with rGP 130 (1:50) and Rd-GAR-Ig (1:100). Only cells with a neuronal morphology are 
stained. (a) GP 130. (b) Phase  contrast. (c, d, and e) In the same cultures an overlapping  staining pattern is seen with neurofilament- 
positive cells. After staining of GP 130 as above, neurofilaments were stained with the monoclonal anti~neurofilament  (1:50) and 
FI-GAM-Ig  (1:100). (c) GP  130. (d) Neurofilaments. (e) Phase contrast.  (f, g, and h) Cultures  from the cerebellum of 13-d-old 
chicken embryos were sequentially  stained after 4 d in vitro with rGP 130 (1:50), Rd-GAR-Ig (1:100), mGalC (1:200), and FI-GAM- 
IgG3 (1:50). GP 130 and GalC are expressed on different cells. Arrows  point out GP 130-positive  cells, empty triangles (in g) 
indicate GalC-positive oligodendrocyte processes. (f) GP 130. (g) GalC. (h) Phase contrast. Bar, 10 ~m. x  650. 
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was estimated by  comparison of densitometer scans of the 
Coomassie-stained  130-kD  gel  band  in  eMCF  with  known 
amounts of actin to give an estimate of the concentration of 
GP 130 in this sample. Densitometer scans of the radiolabeled 
GP 130 band in the same eMCF sample were then compared 
with the radiolabeled band from adult brain to give an esti- 
mate of the amount of GP  130 in the adult brain. According 
to  these  results,  GP  130  comprises  0.2-0.3%  of the  total 
protein in adult chicken brain.  As no correction was made 
for the relatively weaker staining of glycoproteins with Coo- 
FIGURE  6  Trypsin sensitivity of GP  130 in cultured neurons. Cul- 
tures of sympathetic neurons grown for 5 d were treated for various 
time intervals with 1 mg/ml trypsin at pH 7.4 in 150 mM NaCl, 0.1 
M  NaHCO~. The reaction was quenched with an equal volume of 
1 mgJml soybean trypsin inhibitor and 1 mM phenylmethylsulfonyl 
fluoride. Cells were collected in this buffer centrifuged at 800 g and 
processed  for SDS PAGE. GP 130 and the 70,000-mol-wt neurofil- 
ament (NF 70) were detected on Western blots using the appropri- 
ate antisera and 12sI-Protein A. Numbers represent the incubation 
times with trypsin in minutes. 0  min represents  the simultaneous 
addition of trypsin and trypsin inhibitor. 
d-old sympathetic ganglia. As shown in Fig. 7, GP  130 more 
than doubled in content during the time in culture. The level 
of GP  130 in 7-d-old pure neuronal cultures corresponded to 
that in a  13-d-old chicken embryo brain and was considerably 
higher than that in  sympathetic ganglia at any age  embryo 
tested. Immunofluorescence staining with GP  130 antibodies 
could be  observed throughout the entire culture period.  In 
well-developed cultures the staining was more intense than in 
rounded neurons or 24-h cultures. 
GP 130 in Developing and Adult Nervous  Tissue 
The ontogeny of GP  130 was examined with rabbit and 
monoclonal GP 130 antibodies on immunoblots with whole 
brain homogenates from chicken embryos of different ages. 
The relative  amounts of GP  130 in the developing chicken 
embryo brain as determined from densitometer scans of an 
immunoblot with mGP 130-3 are depicted graphically in Fig. 
8. GP 130 was first detected at day 10 after fertilization  and 
increased to ~50%  of its  adult level  at embryonal day  13. 
From this point up to hatching, GP 130 was accumulated at 
considerably lower rates. With all GP 130 antibodies identical 
results were  obtained, although, in some cases, GP  130 was 
detected  as  a  faint  band  in  brain  homogenates  8  d  after 
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FIGURE  7  Expression  of 
GP  130  in  cultured  sym- 
pathetic neurons.  5  ~g of 
total protein from cultures 
grown for 1, 3, and 7 d and 
from  13-d-old  embryo 
brain  were  analyzed  on 
Western  blots  after  incu- 
bation  with  a  mixture  of 
the  six  monoclonal  anti- 
bodies  followed  by  RAM 
and  lZSI-Protein A. After 7 
d  in  culture  the  sympa- 
thetic  neurons  contained 
approximately  the  same 
amount of GP 130 as a 13- 
d-old brain.  (Lane  1)  1-d- 
old culture.  (Lane  2)  3-d- 
old  culture.  (Lane  3)  7-d- 
old culture. (Lane 4) 13-d- 
embryo brain. 
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FIGURE  8  Increase of GP 130 content in developing  chicken brain. 
5/~g of whole brain homogenates from chicken embryos of various 
ages were analyzed on Western blots using mGP 130-3, RAM, and 
12sI-Protein A. Densitometer scans of each track were obtained and 
plotted as shown. Various exposures of the autoradiographs were 
checked to ensure that all the bands were within the linear range. 
(A) Adult level. SCIATIC  NERVE  SYMPATHETIC  GANGLIA 
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FIGURE 9  GP 130 content in developing sciatic nerve and sympathetic ganglia. 5/zg of total protein was analyzed on Western 
blots by incubation with the mixture of monoclonal antibodies  against GP 130 followed by RAM and 12sI-Protein  A. Densitometer 
scans of each track are displayed. Numbers represent days after fertilization. 
massie Brilliant Blue, this is a minimum estimate. 
Regarding the PNS, sciatic nerves from 10-, 15-, and 21-d- 
old chicken embryos were examined for their GP ! 30 content. 
As shown in Fig. 9, it is hard to detect significant differences 
in amounts of GP  130 in sciatic nerve taking into account 
experimental errors. If  anything, amounts of GP 130 seem to 
be lower at day 21  than at day 10 or 15. In another part of 
the PNS, the sympathetic ganglia, GP 130 increased over the 
same developmental period, although, at hatching, the relative 
amount was still  considerably lower than in brain tissue of 
animals of identical age. 
Initial experiments were performed,  in  which  brain  and 
sciatic nerves from a  10-d-old chicken embryos were com- 
pared. The small differences in GP  130 content observed in 
these  tissues  could  be  accounted  for  by  variation  in  the 
percentage  neuronal  membrane  or  by  experimental  error. 
However, the ontogeny of GP  130 suggested that there may 
be a  different distribution  of GP  130  in  the  adult nervous 
system.  As  demonstrated  in  Fig.  10,  amounts  of GP  130 
varied widely between different regions of  the nervous system. 
GP  130  was  most  abundant  in  the  CNS,  with  cerebrum, 
cerebellum,  and  brain  stem showing  the  highest  amounts. 
White matter (dissected by inspection from the midbrain) and 
spinal cord contained less. Particularly striking were the very 
low levels of GP  130 in nerve bundles projecting to or from 
peripheral  (sciatic  nerve,  brachial  nerve)  or  central  targets 
(optic  nerve).  This  result  was  not  due  to  an  incomplete 
dissociation of these nerves, inasmuch as after treatment of 
nerve bundles with  1% collagenase l  for 45 min, identically 
low amounts were  detected  on  immunoblots.  The  relative 
amounts of GP 130 could not be quantitated by densitometry 
of the bands because the variation in intensity was not within 
the linear range of response of the photographic film. Indeed, 
a comparison of the three major brain parts with white matter 
and spinal cord was not possible for this reason. 
DISCUSSION 
Previous work  has  shown  that  GP  130  is  a  cytoskeleton- 
associated glycoprotein. It is tightly associated with actin in 
FIGURE 10  Content  of  GP  130  in  different  parts  of  the  adult 
nervous  system. 5 /zg of total protein was analyzed on Western 
blots by incubation with the mixture of six monoclonal antibodies 
against GP 130 followed by RAM and 12sI-Protein  A. (Lane I) Brain 
stem.  (Lane 2)  Cerebellum. (Lane 3)  Cerebrum.  (Lane 4)  White 
matter. (Lane 5) Spinal cord. (Lane 6) Optic nerve. (Lane 7) Sciatic 
nerve. 
complexes containing approximately 20 major polypeptides. 
Actin cannot be extracted or dissociated without disrupting 
the complexes (10). Two pieces of evidence, presented in this 
paper, suggest that GP 130 is a single molecular species. First, 
the elution profile of the MCF after ion-exchange chromatog- 
raphy showed the 130-kD protein in a single peak as identified 
by staining with both Coomassie and [~25I]-Con  A. Secondly, 
all six monoclonal antibodies and the rabbit antiserum that 
were raised against this  130-kD protein band had identical 
specificities for a neuronal 130-kD antigen which behaved in 
the same way on SDS-polyacrylamide gels and had a closely 
similar,  if not  identical,  course  of development.  However, 
heterogeneity ofGP 130, for example between different classes 
of neurons, cannot be ruled out at present. 
The present data suggest that GP  130 is a  protein unique 
to the nervous system. As judged by the coexpression with 
neurofilaments,  GP  130  is  located  on  neurons  in  cultures 
from both the CNS and PNS. In older cultures from the CNS, 
GP  130 is expressed on additional process-bearing cells that 
do not contain the 210-kD neurofilament polypeptide. This 
result  is  consistent  with  the  observation  that  the  210-kD 
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and that GP 130 is expressed  on most neurons of the CNS 
and  PNS.  Antibodies  against  GP  130  do  not  stain  other 
process-bearing  cells such as oligodendrocytes and occasional 
microglia and, from the chosen culture conditions, it seems 
unlikely that fibrous astrocytes would be present in our CNS 
cultures.  Flat cells expressing f'llamin or fibronectin are never 
recognized by GP 130 antibodies.  In cultures from the PNS, 
these cells comprise the entire non-neuronal cell population 
(32) and, in CNS cultures,  putatively fibroblastlike  cells and 
protoplasmic astrocytes.  These data strongly suggest that GP 
130  is  a  specific  marker  for  chicken  neurons  in  culture. 
Comparison of the  staining with  intact  and  permeabilized 
neurons  in  culture,  together  with  the  evidence  of trypsin 
treatment of cultures,  show that GP 130 is located predomi- 
nantly, if not exclusively,  on the cell surface.  No cross-reac- 
tivity of GP  130 antibodies with  mammalian proteins was 
detected,  although,  in  nervous tissue  of a  phylogenetically 
lower species, lizard,  a protein of identical  molecular weight 
was found to be recognized by GP 130 antibodies.  At present 
it is not known whether different antigen determinants are 
recognized by the monoclonal and polyclonal antibodies. 
Between  1 and 7 d in culture the neurons from sympathetic 
ganglia  form an extensive  network of axons including con- 
spicuous axon bundles.  GP  130 increases  two- to threefold 
during this time.  However, since  GP  130 is located almost 
exclusively  on the  neuronal surface  and the  membrane-to- 
cytoplasmic ratio increases  approximately twofold as axons 
are extended, the change in percentage GP 130 of  total protein 
may be  largely  accounted for by the  increased  fraction of 
plasma membrane. It is difficult  to measure a change in the 
concentration of GP  130  per unit  area  of membrane,  but 
these results suggest that any change would be quite small. 
Three parts of the nervous system were selected for a more 
detailed  examination  of the  appearance  of GP  130 during 
development.  Brain  showed a  striking  increase  in  GP  130 
between days l0 and 13, whereas the content in sciatic nerve 
remained constant or even decreased during days l0 and 21 
of embryonic development.  An  increase  was  observed  in 
sympathetic neurons in vivo and in culture.  This result indi- 
cates a different time course in the ontogeny of sciatic nerve, 
sympathetic ganglia,  and brain.  However, the final  level  of 
GP  130  reached  in  the  adult  chicken  is  quite  distinct  in 
different  regions  of the  nervous  system.  GP  130  is  most 
abundant in cerebrum, cerebellum,  and brain stem,  less in 
spinal  cord and white matter, and present in comparatively 
small  amounts in the PNS and optic nerve.  As discussed  in 
connection with  the  cultures,  neuronal  membrane will  in- 
crease with respect to total protein during differentiation.  This 
is particularly true in regions of  the brain where neurons form 
extensive  dendritic trees. Furthermore, the ratio of neuronal 
to non-neuronal plasma membrane varies within the different 
parts of the nervous system. However, because the difference 
in GP 130 content between,  for example, the cerebellum and 
the sciatic nerve considerably exceeds an order of magnitude, 
these explanations alone may be insufficient.  It is conceivable 
that  GP  130  may be  more concentrated per  unit  area  of 
neuronal membrane in points of interneuronal contact such 
as dendritic spines  and synapses.  Unfortunately, there is as 
yet no specific neuronal membrane marker of uniform distri- 
bution with which to compare our results and thus clarify this 
issue. 
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Whatever the subcellular  concentration and function of  GP 
130 in the nervous system, the antibodies should be valuable 
as  markers  for chicken  neurons and  as tools to  study the 
development of connections between the neuronal cytoskel- 
eton to molecules from the environment. 
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